Published by Nicolas Tierney
November 11, 2020
Often, well-intentioned healthcare practitioners do not have access to the current science or clinical best practices supporting safe and efficacious regenerative medicine procedures. Worse, so-called “bad actors” in the field are promoting various therapies and products with little or no scientific basis. As a result, patients often receive “regenerative therapies” resulting in poor outcomes, unreasonably high costs and/or little transparency.
RMSNY is a product-agnostic organization led by internationally recognized scientific and clinical thought leaders. Its clinical members have a simple yet powerful mission – providing their patients with evidence-based, regulatorily-compliant and reasonably-priced regenerative medicine procedures in a transparent manner. Our goal is safe, predictable and demonstrably better outcomes.
More information on RMSNY, its leadership, membership and mission can be found on its website.
Read The Latest
June 16, 2021
CELLS, or the “Clinical Evidence Leadership Lecture Series”, is back in a new digital format. Featuring clinician leaders from around the world, these ...
June 9, 2021
Poor patient engagement can lead to non-compliance, adverse outcomes and substantial expense. (Lack of medicinal adherence costs the US healthcare system ...